SG11201510003VA - Anti-fibrogenic compounds, methods and uses thereof - Google Patents
Anti-fibrogenic compounds, methods and uses thereofInfo
- Publication number
- SG11201510003VA SG11201510003VA SG11201510003VA SG11201510003VA SG11201510003VA SG 11201510003V A SG11201510003V A SG 11201510003VA SG 11201510003V A SG11201510003V A SG 11201510003VA SG 11201510003V A SG11201510003V A SG 11201510003VA SG 11201510003V A SG11201510003V A SG 11201510003VA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- fibrogenic
- compounds
- fibrogenic compounds
- Prior art date
Links
- 230000000434 anti-fibrogenic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361831404P | 2013-06-05 | 2013-06-05 | |
PCT/CA2014/000484 WO2014194407A1 (en) | 2013-06-05 | 2014-06-04 | Anti-fibrogenic compounds, methods and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201510003VA true SG11201510003VA (en) | 2016-01-28 |
Family
ID=52007349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201510003VA SG11201510003VA (en) | 2013-06-05 | 2014-06-04 | Anti-fibrogenic compounds, methods and uses thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US9737523B2 (en) |
EP (1) | EP3003298B1 (en) |
JP (1) | JP6473938B2 (en) |
KR (1) | KR102294405B1 (en) |
AU (1) | AU2014277568B2 (en) |
CA (1) | CA2914261C (en) |
PH (1) | PH12015502717A1 (en) |
RU (1) | RU2726416C2 (en) |
SG (1) | SG11201510003VA (en) |
WO (1) | WO2014194407A1 (en) |
ZA (1) | ZA201600015B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10779517B2 (en) | 2017-01-31 | 2020-09-22 | The Board Of Regents Of The University Of Oklahoma | Animal wound model and methods of use |
CN112168822B (en) * | 2020-09-27 | 2022-11-08 | 集美大学 | Application of kynurenic acid in improving hyperlipidemia induced dyslipidemia, obesity and intestinal flora disorder |
AU2022269054A1 (en) * | 2021-05-07 | 2023-11-23 | Birchbiomed Inc. | Methods of using a small molecule chemical compound to reduce the appearance of post-acne atrophic scarring |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
EP1369114A1 (en) | 2002-06-07 | 2003-12-10 | Peter Priv. Doz. Dr. Terness | Use of tryptophan metabolites as pharmaceutical agents |
AU2002950217A0 (en) * | 2002-07-16 | 2002-09-12 | Prana Biotechnology Limited | 8- Hydroxy Quinoline Derivatives |
KR20070102670A (en) * | 2004-11-17 | 2007-10-19 | 앤지오젠 파마슈티칼스 피티와이. 리미티드 | A method of modulating b cell functioning |
HUP0700051A2 (en) | 2007-01-17 | 2008-09-29 | Univ Szegedi | Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation |
BR112014030835B1 (en) * | 2012-06-15 | 2022-01-11 | Conaris Research Institute Ag | COMPOSITION CONTAINING NICOTINIC ACID AND/OR NICOTINAMIDE AND/OR TRYPTOPHAN, AND USE THEREOF |
-
2014
- 2014-06-04 KR KR1020167000203A patent/KR102294405B1/en active IP Right Grant
- 2014-06-04 CA CA2914261A patent/CA2914261C/en active Active
- 2014-06-04 RU RU2015156196A patent/RU2726416C2/en active
- 2014-06-04 WO PCT/CA2014/000484 patent/WO2014194407A1/en active Application Filing
- 2014-06-04 SG SG11201510003VA patent/SG11201510003VA/en unknown
- 2014-06-04 US US14/896,269 patent/US9737523B2/en active Active
- 2014-06-04 AU AU2014277568A patent/AU2014277568B2/en active Active
- 2014-06-04 EP EP14806967.7A patent/EP3003298B1/en active Active
- 2014-06-04 JP JP2016517101A patent/JP6473938B2/en active Active
-
2015
- 2015-12-04 PH PH12015502717A patent/PH12015502717A1/en unknown
-
2016
- 2016-01-04 ZA ZA2016/00015A patent/ZA201600015B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US9737523B2 (en) | 2017-08-22 |
RU2015156196A3 (en) | 2018-05-24 |
AU2014277568A1 (en) | 2016-01-28 |
ZA201600015B (en) | 2019-07-31 |
EP3003298A4 (en) | 2017-03-22 |
BR112015030569A2 (en) | 2017-07-25 |
KR102294405B1 (en) | 2021-08-25 |
PH12015502717A1 (en) | 2016-03-14 |
KR20160018676A (en) | 2016-02-17 |
EP3003298A1 (en) | 2016-04-13 |
RU2726416C2 (en) | 2020-07-14 |
NZ715579A (en) | 2021-05-28 |
BR112015030569A8 (en) | 2020-01-07 |
RU2015156196A (en) | 2017-07-14 |
CA2914261A1 (en) | 2014-12-11 |
WO2014194407A1 (en) | 2014-12-11 |
AU2014277568B2 (en) | 2019-09-19 |
JP6473938B2 (en) | 2019-02-27 |
US20160120857A1 (en) | 2016-05-05 |
CA2914261C (en) | 2020-02-11 |
EP3003298B1 (en) | 2024-03-20 |
JP2016521695A (en) | 2016-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274355B (en) | Aza-pyridone compounds and uses thereof | |
GB201323008D0 (en) | Compounds and uses thereof | |
GB201317802D0 (en) | SmartHaler patent application | |
GB201312318D0 (en) | Novel methods and compounds | |
EP3012292A4 (en) | Processing aid, and composition | |
GB201306980D0 (en) | Methods | |
GB201300707D0 (en) | Compounds and processes | |
HK1223111A1 (en) | Methods | |
GB201307233D0 (en) | Compounds and uses thereof | |
GB201411896D0 (en) | . | |
GB201312444D0 (en) | Methods | |
GB201308516D0 (en) | Methods | |
GB201309180D0 (en) | Compounds and Their Uses | |
HK1223307A1 (en) | Novel compounds and uses thereof | |
ZA201600015B (en) | Anti-fibrogenic compounds, methods and uses thereof | |
GB201314610D0 (en) | Compounds and their uses | |
GB201306248D0 (en) | Compounds and their uses | |
GB201304234D0 (en) | Methods | |
ZA201601880B (en) | Hetero-transglycosylase and uses thereof | |
HK1218781A1 (en) | Methods | |
GB201323005D0 (en) | Compounds and uses thereof | |
GB201312935D0 (en) | T,b,s | |
GB201307201D0 (en) | New compounds and uses | |
GB201307202D0 (en) | New compounds and uses | |
GB201409791D0 (en) | . |